Overview
Grasp the entire antibody‑engineering workflow – from discovery and hybridoma tech to CAR‑T, bi-specifics, and ADCs., Decode antibody structure–function basics and see how molecular tweaks boost affinity, stability, and safety., Compare cutting‑edge platforms like phage/yeast display, transgenic animals, and in‑silico design for rapid hit discovery., Apply real‑world case studies (Blinatumomab, CAR‑T therapies) to plan R&D or clinical strategies.
Life‑science students exploring biotech careers for building a rock‑solid antibody engineering foundation for internships or MSc/PhD applications., Bench scientists / research associates moving into biologics for fast‑tracking your transition from small‑molecule or academic work to therapeutic antibody projects., Clinicians & pharmacists wanting to interpret clinical trial data, advise patients, and collaborate with R&D teams more confidently., Entrepreneurial founders & investors eyeing next‑gen biologics to spot technological white‑spaces and evaluate platform start‑ups with a scientific lens., Curious self‑learners who love immunology breakthroughs to enjoy an engaging, jargon‑free tour of the science behind today’s blockbuster biologics.
High‑school level biology or first‑year university life‑science knowledge., Curiosity about biologics, immunology, or drug development., No lab access required – all concepts are explained visually.
Unlock the world of antibody engineering in this foundational course designed for students, researchers, and life science professionals. Whether you're new to biotechnology or looking to solidify your understanding of antibody-based therapeutics, this course provides a structured, beginner-friendly introduction to one of the most powerful tools in modern medicine.
You will begin with the discovery and structural properties of antibodies and quickly move into revolutionary technologies like hybridoma systems, antibody display platforms (e.g., phage, mammalian and yeast display), and humanized antibody production using transgenic animals. I will explore how these engineered antibodies are reshaping therapeutic strategies in cancer, autoimmune disease, and infectious disease.
Dive deeper into cutting-edge antibody modalities, including bispecific antibodies, antibody-drug conjugates (ADCs), and CAR-T cell therapy. These tools are transforming clinical outcomes for patients with previously untreatable diseases.
By the end, you will be equipped with the foundational knowledge to understand antibody therapeutics, contribute to research teams, or pursue more advanced training.
No prior experience in immunology is required—just curiosity and a passion for science and innovation.
What You will Learn:
Basics of antibody structure and function
How monoclonal antibodies are made using hybridomas
How display systems revolutionized antibody selection
The use of antibodies in diagnostics and therapy
Mechanisms of bispecific antibodies and ADCs
The role of antibodies in CAR-T cells and future applications
Dr. Amogh Gopinathan Nair
Dr. Amogh Gopinathan Nair, Ph.D
Immuno-Oncology & Stem Cell Scientist | Antibody Engineering & AI-Driven Drug Discovery | Regulatory Affairs & Translational Research Expert | 15+ Years in Academia & Industry | Merck-MITACS and Lonza-Trained
Hello everyone, I am Dr. Amogh Nair, a scientist-educator with over 15 years of experience at the intersection of cutting-edge biology and real-world drug development—from discovery to IND-enabling studies, clinical trial design, and early market access. Trained in both academic rigor and industry precision, I specialize in therapeutic antibody engineering, immuno-oncology, stem cell technologies, AI-enhanced drug discovery, and regulatory strategy.
My professional journey has taken me from GMP-driven cell line development at Lonza to CRISPR-edited iPSC models at the University of Sheffield, and from multi-specific antibody development in clinical-stage oncology programs to regulatory interactions with global health authorities.
Areas of Expertise:
Antibody Engineering (hybridoma, bi-specifics, ADCs, CAR-T)
Stem Cells & Organoids (hESCs, iPSCs, CRISPR/TALEN, disease modeling)
Immuno-Oncology (tumor biology, MOA studies, biomarker integration)
AI in Drug Discovery (epitope prediction, HT screening, lead optimization)
Regulatory Affairs (preclinical strategy, IND packages, trial design, market access)
As Your Instructor, I Offer:
Clarity & Context – I break down complex topics into actionable insights for biotech, clinical, and regulatory learners.
Real-World Relevance – Every concept connects to current therapeutics, real drug programs, and actual regulatory decisions.
Career-Ready Knowledge – Whether you are transitioning from academia or upskilling in biotech, I teach with the mindset of industry readiness.
Featured Course Topics:
Antibody Engineering for Oncology and Cardio-metabolic diseases (GLP-1, GIP, GCGR) – structure, function, platforms, clinical relevance
CAR-T & Biologics – core concepts, applications, safety, and scalability
AI & Drug Discovery – predictive tools, pipeline acceleration, integration with wet-lab research
Stem Cell Biology in Medicine – iPSC technologies, Organoids, “clinical trials in a dish” and AI integration.
Regulatory Pathways – how therapeutics move from bench to bedside
Outside the lab, I am a dedicated trail runner and culinary explorer—both of which teach the same lesson I bring into the classroom: exploration, precision, patience, and purpose.
If you are seeking an instructor who brings deep scientific knowledge, cross-functional experience, and a passion for clear, impactful teaching, you are in the right place.
Go ahead, learn the skills and explore.